The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells via the p21 signaling pathway
- 1University of Chinese Academy of Sciences (UCAS) Chongqing School, Chongqing Medical University, Chongqing, China
- 2Chongqing Institute of Green and Intelligent Technology, Chinese Academy of Sciences (CAS), Chongqing, China
- 3Chongqing School, University of Chinese Academy of Sciences (UCAS), Chongqing, China
- 4Institute of Hepatopancreatobiliary Surgery, Chongqing General Hospital, University of Chinese Academy of Sciences (UCAS Chongqing), Chongqing, China
- 5Chongqing Key Laboratory of Intelligent Medicine Engineering for Hepatopancreatobiliary Diseases, Chongqing General Hospital, Chongqing, China
- 6Savaid Medical School, University of Chinese Academy of Sciences (UCAS), Beijing, China
- 7Department of Hepatobiliary Surgery, Hainan Hospital of People’s Liberation Army of China (PLA) General Hospital, Sanya, China
A Corrigendum on
The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells via the p21 signaling pathway
by Xie F, Zheng Y, Fu W, Chi B, Wang X, Zhang J, Gu J, Yin J, Zhou Q, Guo S, Cai L, Yang J, Liu S and Wang H (2023) Front. Oncol. 13:1138238. doi: 10.3389/fonc.2023.1138238
Error in Figure/Table
In the published article, there was an error in Figures 3D, F as published. The incorrect images were included. The corrected Figures 3D, F and its caption appear below.
Figure 3 METTL16 inhibits tumor growth in mice. (A) Nude mice were subcutaneously implanted with sh-NC or sh-METTL16 PC cells, and subcutaneous tumor nodules formed in the two groups of mice. (B) The weekly tumor volumes of the METTL16-knockdown and control groups are presented in the chart. (C) The mean tumor weights of the METTL16-knockdown and control groups 6 weeks after inoculation are presented. Two groups of tumor specimens were subjected to immunohistochemical detection of METTL16 (D, G), PCNA (E, H) and Ki67 (F, I). * means p<0.05; ** means p<0.01; *** means p<0.001.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: pancreatic adenocarcinoma, METTL16, m6A, p21, cell proliferation
Citation: Xie F, Zheng Y, Fu W, Chi B, Wang X, Zhang J, Gu J, Yin J, Zhou Q, Guo S, Cai L, Yang J, Liu S and Wang H (2023) Corrigendum: The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells via the p21 signaling pathway. Front. Oncol. 13:1218781. doi: 10.3389/fonc.2023.1218781
Received: 08 May 2023; Accepted: 09 May 2023;
Published: 19 May 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Xie, Zheng, Fu, Chi, Wang, Zhang, Gu, Yin, Zhou, Guo, Cai, Yang, Liu and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jiali Yang, xj_yangjiali@163.com; Songsong Liu, songsliu@126.com; Huaizhi Wang, whuaizhi@gmail.com
†These authors have contributed equally to this work